SCHEMBL24400400

SCHEMBL24400400

NCc1ccc(Oc2ccc(C(F)(F)F)nc2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 4/20 0.40
LOX P28300 2/20 0.40
PLAAT3 P53816 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT2 Q9NWW9 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAOB P27338 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
SCN9A Q15858 1/20 0.38
LIPE Q05469 1/20 0.38
CSF1R P07333 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TRPV4 Q9HBA0 1/20 0.38
THRB P10828 1/20 0.37
DAO P14920 1/20 0.37
CHRNB2 P17787 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4375266 0.85 ST14 (0.50) LOXL2LOXPLAAT3PLAAT5PLAAT2
SCHEMBL29404783 0.83 LOXL2 (0.53) LOXL2LOXMAPTMAOBTRPV4
SCHEMBL40545 0.83 LOXL2 (0.53) LOXL2LOXMAPTMAOBTRPV4
SCHEMBL24401094 0.82 LOXL2 (0.41) LOXL2LOXPLAAT3PLAAT5PLAAT2
SCHEMBL24400581 0.82 THRB (0.39) LOXL2LOXMAPTNPSR1MAOB
Hydrochloric Acid SCHEMBL3494124 0.81 LOXL2 (0.55) LOXL2LOXMAPTMAOBTRPV4
SCHEMBL6506743 0.81 KDM4E (0.59) MAPTNPSR1SCN9AKDM4EMEN1
SCHEMBL4368145 0.79 LOXL2 (0.48) LOXL2LOXMAOBSCN9A
SCHEMBL4380974 0.77 MEN1 (0.63) LOXL2MAOBKDM4EMEN1KMT2A
SCHEMBL30744447 0.77 MEN1 (0.63) LOXL2MAOBKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4238974-A1 HIGH-ACTIVITY WNT PATHWAY INHIBITOR COMPOUND Adlai Nortye Biopharma Co., Ltd. (CN) 2023-09-06 EP disclosed
WO-2022089454-A1 HIGH-ACTIVITY WNT PATHWAY INHIBITOR COMPOUND 杭州阿诺生物医药科技有限公司 2022-05-05 WO disclosed